Hawthorne Effect Secures $20M to Decentralize Clinical Trials
Hawthorne Effect, a solution for decentralizing clinical trials, announced it has raised $20M in Series A funding led by Northpond Ventures
Stay updated with breaking news from Hawthrone Effect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hawthorne Effect, a solution for decentralizing clinical trials, announced it has raised $20M in Series A funding led by Northpond Ventures
The round was led by Northpond Ventures, with participation from SignalFire and P5 Health Ventures. The company intends to use the funds to accelerate growth and help scale operations. Led by Jodi Akin, CEO and founder, Hawthorne Effect provides a solution for decentralizing clinical trials to alleviate key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical professionals. The company’s tech-driven platform, the Hawthorne Cloud, works with highly trained medical professionals, called Hawthorne Heroes, to deliver complete assess...